ENERGIZER
14.2.2019 10:02:08 CET | Business Wire | Press release
Avenir Telecom, under exclusive Energizer ® licence, will unveil its highly-anticipated Power Max P18K Pop at the MWC19. This unique smartphone incorporates five cameras, a large 6.2" FHD+ screen and an 18,000 mAh battery — the highest capacity battery ever seen in a smartphone which guarantees weeks of battery life on a single charge.
18,000 mAh: the 1 st smartphone to feature such a powerful battery
With battery life posing a real challenge, the Power Max P18K Pop stays true to the Energizer ® 's range of long-lasting products. This new smartphone incorporates unrivalled technological advances as it features the most powerful battery ever developed for a smartphone, offering a concrete solution to the needs of the modern day users. The optimization of the software and the operating system help extend battery life, promising a seamless consumer experience.
Users will be able to make up to 90hrs of calls, listen to 100hrs of music and watch around 2 days of video on a single charge . In standby mode, the battery lasts up to 50 days. And when a full charge is necessary, users can recharge their device quickly thanks to the fast charge function.
The Pop-up cameras revolution!
Nothing has been left behind when designing the P18K Pop. The Energizer ® smartphone is among the first to feature five cameras , of which TWO are front-facing in a "pop-up" housing. The 16MP and 2MP lenses promise users sharp, bright images. The P18K features 3 rear cameras (12MP+5MP+2MP), which together produce incredibly bright shots with stunning depth of field for a professional finish.
The introduction of Pop-Up technology allows for a fully uninterrupted screen. The 6.2" FHD+ screen offers exceptional image quality with rich colours and strong contrast.
Delivering high-level performance
Performance has been placed at the heart of the P18K Pop's development to deliver a smarter and faster smartphone. It offers 6GB of RAM and 128GB of storage to enable users to switch from app to app with ease and store thousands of multimedia files. The MediaTek Helio P70 chipset ensures agility and speed across a range of tasks delivering an enjoyable user experience.
The Energizer ® P18K Pop will be unveiled at the MWC (#CS96 @Congress Square). Avenir Telecom will take orders at the show for delivery this summer. Contact us to schedule testing: press@avenir-telecom.fr .
Download HD images here
View source version on businesswire.com: https://www.businesswire.com/news/home/20190214005055/en/
Contact:
Lucile Devictor, Communication Manager ldevictor@avenir-telecom.fr +33-(0)-4-88-00-60-29 http://energizermobile.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Imagine Dragons to Perform at Abu Dhabi Grand Prix21.5.2026 17:51:00 CEST | Press release
Ethara, organiser of the Formula 1 Etihad Airways Abu Dhabi Grand Prix, have announced that one of the world’s biggest bands, Imagine Dragons, will headline the Saturday After-Race Concerts at the F1 Season Finale in Abu Dhabi. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521214839/en/ Imagine Dragons to perform at Formula 1 Etihad Airways Abu Dhabi Grand Prix (Photo: AETOSWire) The announcement is another landmark moment for the Abu Dhabi Grand Prix, whose thrilling Yasalam presented by e& fan entertainment offering has become synonymous with the F1 Championship finale in Abu Dhabi and is recognised as one of the most compelling sports and entertainment crossovers globally. The global chart-toppers join Lewis Capaldi and Zara Larsson, who are set to kick off a blockbuster line-up of performances on Yas Island on Thursday, 3 December, with more major international artists to be revealed. With their popular top hits, Ima
Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 14:05:00 CEST | Press release
Trained on more than 13,000 patient studies, novel system significantly outperforms existing models by up to 35% A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is d
Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 14:00:00 CEST | Press release
A growing wave of unsupported solar systems and rising electricity prices are creating strong demand for Otovo’s energy service platform Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensu
The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 14:00:00 CEST | Press release
New research shows that brands aligned with emotionally heightened moments in live sports can improve ad effectiveness Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The r
Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 14:00:00 CEST | Press release
Precemtabart tocentecan (Precem-TcT) is investigated as a potential first-in-class anti-CEACAM5 ADC, for the treatment of metastatic CRC (mCRC) CEACAM5 is overexpressed in the majority of colorectal tumors (~90%), and requires no patient selection Significant unmet need remains for clinically meaningful innovation in colorectal cancer (CRC), the second leading cause of cancer death worldwide Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom